NO20016347L - Expression regulatory system using nuclear PPAR receptors and their ligands - Google Patents

Expression regulatory system using nuclear PPAR receptors and their ligands

Info

Publication number
NO20016347L
NO20016347L NO20016347A NO20016347A NO20016347L NO 20016347 L NO20016347 L NO 20016347L NO 20016347 A NO20016347 A NO 20016347A NO 20016347 A NO20016347 A NO 20016347A NO 20016347 L NO20016347 L NO 20016347L
Authority
NO
Norway
Prior art keywords
ligands
expression regulatory
regulatory system
ppar receptors
nuclear ppar
Prior art date
Application number
NO20016347A
Other languages
Norwegian (no)
Other versions
NO20016347D0 (en
Inventor
Raphael Darteil
Joel Crouzet
Bart Staels
Abderrahim Mahfoudi
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9907957A external-priority patent/FR2795425B1/en
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of NO20016347D0 publication Critical patent/NO20016347D0/en
Publication of NO20016347L publication Critical patent/NO20016347L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
    • C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/42—Vector systems having a special element relevant for transcription being an intron or intervening sequence for splicing and/or stability of RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20016347A 1999-06-22 2001-12-21 Expression regulatory system using nuclear PPAR receptors and their ligands NO20016347L (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9907957A FR2795425B1 (en) 1999-06-22 1999-06-22 PHARMACOLOGICAL REGULATION OF EXPRESSION SYSTEM USING NUCLEAR RECEPTORS BY AND THEIR LIGANDS
US14972199P 1999-08-20 1999-08-20
PCT/FR2000/001744 WO2000078986A1 (en) 1999-06-22 2000-06-22 Regulation system of expression using nuclear ppar receptors

Publications (2)

Publication Number Publication Date
NO20016347D0 NO20016347D0 (en) 2001-12-21
NO20016347L true NO20016347L (en) 2002-02-19

Family

ID=26234999

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20016347A NO20016347L (en) 1999-06-22 2001-12-21 Expression regulatory system using nuclear PPAR receptors and their ligands

Country Status (14)

Country Link
EP (1) EP1190084A1 (en)
JP (1) JP2003503034A (en)
KR (1) KR20020028909A (en)
CN (1) CN1370240A (en)
AU (1) AU6164500A (en)
BR (1) BR0011897A (en)
CA (1) CA2375869A1 (en)
CZ (1) CZ20014609A3 (en)
HU (1) HUP0203584A2 (en)
IL (1) IL147104A0 (en)
MX (1) MXPA01013227A (en)
NO (1) NO20016347L (en)
NZ (1) NZ516678A (en)
WO (1) WO2000078986A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2403189A1 (en) * 2000-03-14 2001-09-20 Charbel Massaad Inflammation-inducible hybrid promoters, vectors containing same and uses thereof
EP1288303A1 (en) * 2001-08-23 2003-03-05 Aventis Pharma S.A. Inducible expression systems employing PPAR transcriptional activators
WO2003012113A2 (en) * 2001-08-02 2003-02-13 Gencell S.A. Inducible expression systems employing ppar transcriptional activators
WO2014117945A2 (en) * 2013-02-04 2014-08-07 Eth Zurich Designer circuit controlling diet-induced obesity
CN107779454A (en) * 2016-08-31 2018-03-09 上海米络凯生物科技有限公司 The structure of medicaments sifting model based on PPAR γ signal paths and application

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10502256A (en) * 1994-07-01 1998-03-03 ザ ソールク インスチチュート フォア バイオロジカル スタディズ Mammalian peroxisome proliferator-activated receptor and uses thereof
FR2755699B1 (en) * 1996-11-08 1998-12-18 Rhone Poulenc Rorer Sa NEW CONSTRUCTIONS AND VECTORS FOR TARGETED AND INDUCTIBLE GENE EXPRESSION

Also Published As

Publication number Publication date
IL147104A0 (en) 2002-08-14
BR0011897A (en) 2002-03-26
NZ516678A (en) 2004-04-30
CZ20014609A3 (en) 2002-05-15
WO2000078986B1 (en) 2001-04-19
HUP0203584A2 (en) 2003-02-28
EP1190084A1 (en) 2002-03-27
MXPA01013227A (en) 2002-06-04
CA2375869A1 (en) 2000-12-28
KR20020028909A (en) 2002-04-17
JP2003503034A (en) 2003-01-28
NO20016347D0 (en) 2001-12-21
CN1370240A (en) 2002-09-18
AU6164500A (en) 2001-01-09
WO2000078986A1 (en) 2000-12-28

Similar Documents

Publication Publication Date Title
DE60044748D1 (en) SYSTEM FOR WOUND CLOSURE
NO20014817L (en) Water dispenser with filter integrity system
NO20013777D0 (en) Procedure for carrying out non-cash payment and system for carrying out the procedure
NO20021988D0 (en) Deposits monitoring system
DK1200926T3 (en) Cardless payment system
NO20022095D0 (en) Heterocyclic substituted pyrazolones
NO20013157D0 (en) Preparations for cardiovascular indications
FI990170A (en) payment Reference
DE60007050D1 (en) IMC process
NO981804L (en) Wellbore Completion Unit
DE69804635T2 (en) BRANCHED ALKOXY-SUBSTITUTED 2-AMINOPYRIDINE AS NOS INHIBITORS
NO20022853D0 (en) Multiprocessor Management System and Procedure
NO20016347L (en) Expression regulatory system using nuclear PPAR receptors and their ligands
NO20021366L (en) Network port for transaction processing network
DE60028202D1 (en) CONTAINER FOR THE INCLUSION OF CORE BURNER ELEMENTS
NO20012202L (en) Linseformb¶rer
DE50015434D1 (en) Multiprocessor system
NO20014416D0 (en) Seismic modeling method
DE60002809D1 (en) Secure computer system
DE60000817D1 (en) CALIXAR DERIVATIVES FOR EXTRACTION OF ACTINIDES
NO976016L (en) Device for snubing rig
DE29700151U1 (en) Security tank
DE29906967U1 (en) formwork
DE50000564D1 (en) Using a pipe
IDP000026268A (en) Q3T INTERFACE FOR FIBER ACCESS NETWORK

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application